Nornuciferidine
Internal ID | 1543f570-11f5-4b35-8240-4ebc12604933 |
Taxonomy | Alkaloids and derivatives > Aporphines > Hydroxy-7-aporphines |
IUPAC Name | (6aS,7S)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-7-ol |
SMILES (Canonical) | COC1=C(C2=C3C(C(C4=CC=CC=C42)O)NCCC3=C1)OC |
SMILES (Isomeric) | COC1=C(C2=C3[C@@H]([C@H](C4=CC=CC=C42)O)NCCC3=C1)OC |
InChI | InChI=1S/C18H19NO3/c1-21-13-9-10-7-8-19-16-14(10)15(18(13)22-2)11-5-3-4-6-12(11)17(16)20/h3-6,9,16-17,19-20H,7-8H2,1-2H3/t16-,17-/m0/s1 |
InChI Key | KFMXRGXNQZECTP-IRXDYDNUSA-N |
Popularity | 3 references in papers |
Molecular Formula | C18H19NO3 |
Molecular Weight | 297.30 g/mol |
Exact Mass | 297.13649347 g/mol |
Topological Polar Surface Area (TPSA) | 50.70 Ų |
XlogP | 1.90 |
Atomic LogP (AlogP) | 2.60 |
H-Bond Acceptor | 4 |
H-Bond Donor | 2 |
Rotatable Bonds | 2 |
112494-69-6 |
(6aS,7S)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-7-ol |
CHEMBL4279962 |
DTXSID30150067 |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9535 | 95.35% |
Caco-2 | + | 0.8728 | 87.28% |
Blood Brain Barrier | - | 0.5000 | 50.00% |
Human oral bioavailability | + | 0.6000 | 60.00% |
Subcellular localzation | Mitochondria | 0.5800 | 58.00% |
OATP2B1 inhibitior | - | 0.8599 | 85.99% |
OATP1B1 inhibitior | + | 0.9172 | 91.72% |
OATP1B3 inhibitior | + | 0.9661 | 96.61% |
MATE1 inhibitior | - | 0.9400 | 94.00% |
OCT2 inhibitior | - | 0.7250 | 72.50% |
BSEP inhibitior | + | 0.5626 | 56.26% |
P-glycoprotein inhibitior | - | 0.6672 | 66.72% |
P-glycoprotein substrate | + | 0.5052 | 50.52% |
CYP3A4 substrate | + | 0.6417 | 64.17% |
CYP2C9 substrate | - | 0.5942 | 59.42% |
CYP2D6 substrate | + | 0.8055 | 80.55% |
CYP3A4 inhibition | - | 0.9433 | 94.33% |
CYP2C9 inhibition | - | 0.9311 | 93.11% |
CYP2C19 inhibition | - | 0.8473 | 84.73% |
CYP2D6 inhibition | - | 0.8341 | 83.41% |
CYP1A2 inhibition | - | 0.7800 | 78.00% |
CYP2C8 inhibition | + | 0.7166 | 71.66% |
CYP inhibitory promiscuity | - | 0.8919 | 89.19% |
UGT catelyzed | - | 0.5000 | 50.00% |
Carcinogenicity (binary) | - | 0.9600 | 96.00% |
Carcinogenicity (trinary) | Non-required | 0.7369 | 73.69% |
Eye corrosion | - | 0.9873 | 98.73% |
Eye irritation | - | 0.9868 | 98.68% |
Skin irritation | - | 0.7042 | 70.42% |
Skin corrosion | - | 0.8974 | 89.74% |
Ames mutagenesis | + | 0.6100 | 61.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6437 | 64.37% |
Micronuclear | + | 0.6000 | 60.00% |
Hepatotoxicity | - | 0.6375 | 63.75% |
skin sensitisation | - | 0.8541 | 85.41% |
Respiratory toxicity | + | 0.6889 | 68.89% |
Reproductive toxicity | + | 0.8444 | 84.44% |
Mitochondrial toxicity | + | 0.8125 | 81.25% |
Nephrotoxicity | - | 0.8187 | 81.87% |
Acute Oral Toxicity (c) | III | 0.5021 | 50.21% |
Estrogen receptor binding | + | 0.5513 | 55.13% |
Androgen receptor binding | + | 0.6670 | 66.70% |
Thyroid receptor binding | + | 0.6870 | 68.70% |
Glucocorticoid receptor binding | + | 0.6174 | 61.74% |
Aromatase binding | - | 0.6000 | 60.00% |
PPAR gamma | + | 0.5701 | 57.01% |
Honey bee toxicity | - | 0.8722 | 87.22% |
Biodegradation | - | 0.9000 | 90.00% |
Crustacea aquatic toxicity | + | 0.6451 | 64.51% |
Fish aquatic toxicity | - | 0.8915 | 89.15% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1942 | P18089 | Alpha-2b adrenergic receptor |
571 nM |
Ki |
via Super-PRED
|
CHEMBL213 | P08588 | Beta-1 adrenergic receptor |
1.7 nM |
IC50 |
via Super-PRED
|
CHEMBL210 | P07550 | Beta-2 adrenergic receptor |
1.4 nM 210 nM |
IC50 IC50 |
via Super-PRED
via Super-PRED |
CHEMBL246 | P13945 | Beta-3 adrenergic receptor |
240 nM |
IC50 |
via Super-PRED
|
CHEMBL214 | P08908 | Serotonin 1a (5-HT1a) receptor |
71 nM |
Ki |
via Super-PRED
|
CHEMBL1983 | P28221 | Serotonin 1d (5-HT1d) receptor |
857 nM |
Ki |
via Super-PRED
|
CHEMBL1833 | P41595 | Serotonin 2b (5-HT2b) receptor |
246 nM |
Ki |
via Super-PRED
|
CHEMBL3371 | P50406 | Serotonin 6 (5-HT6) receptor |
862 nM |
Ki |
via Super-PRED
|
CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor |
120 nM |
Ki |
via Super-PRED
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.45% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.46% | 91.11% |
CHEMBL2581 | P07339 | Cathepsin D | 94.52% | 98.95% |
CHEMBL2535 | P11166 | Glucose transporter | 93.58% | 98.75% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 88.79% | 86.33% |
CHEMBL2056 | P21728 | Dopamine D1 receptor | 87.99% | 91.00% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 87.80% | 99.17% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 87.22% | 97.09% |
CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 85.82% | 93.99% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.05% | 95.56% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.17% | 95.89% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 83.04% | 92.62% |
CHEMBL4145 | Q9UKV0 | Histone deacetylase 9 | 82.51% | 85.49% |
CHEMBL5028 | O14672 | ADAM10 | 82.13% | 97.50% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 80.96% | 89.00% |
CHEMBL2378 | P30307 | Dual specificity phosphatase Cdc25C | 80.26% | 96.67% |
CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 80.16% | 93.03% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Nelumbo nucifera |